This project, a response to notice number NOT-OD-10-032 and notice title NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications (R01, R03, R15, R21/R33, and R37) through the NIH Basic Behavioral and Social Science Opportunity Network (OppNet), focuses on approaches to data analysis that allow researchers to investigate underlying mechanisms and processes of mental health and behavioral problems that are targeted by prevention and treatment programs in a wide range of behavioral research areas. Specifically, the work will evaluate statistical modeling approaches that can be used to examine processes targeted by prevention and treatment programs (mediators) when outcomes are measured as time until the onset of an event (survival data), and thereby provide guidance to researchers who consider using these approaches. The parent grant focuses on treatment for major depressive disorder, but as part of the proposal, collaboration will be established with a leading methodological and health promotion and disease prevention researcher. Furthermore, these approaches would apply to mental health disorders other than depression, to substance abuse, and to health behaviors (e.g., weight control), and need not be utilized in the context of applied research, though they will be in the case of the parent grant. The parent grant, Prevention of Recurrence in Depression with Drugs and Cognitive Therapy, is an NIMH-funded multi-site trial in which depressed outpatients have been randomized to antidepressant medications (ADM) alone or to ADM and cognitive therapy (CT). It was designed with power sufficient to: 1) detect benefits that might accompany the addition of CT to ADM with respect to treatment response and the prevention of recurrence, and 2) explore predictors and underlying processes that are targeted by the treatments, and assess their relationships to symptom improvement (a basic behavioral and social sciences research goal), potentially elucidating how additional benefits might accrue from adding CT and providing information about how to improve treatments for depression. Measures of multiple kinds of cognitive changes and treatment processes are being collected in order to test hypotheses about these constructs as underlying mechanisms of symptom improvement. The proposed simulation work, which is not included in the original parent grant, will help to ensure that the best approaches are used to achieve this aim.

Public Health Relevance

Depression is one of the most prevalent and debilitating of the psychiatric disorders. By yielding estimates of the benefit of adding psychotherapy to medication therapy in the treatment of depression, and identifying subgroups of patients who most benefit from combined treatment, findings from this project will be able to guide clinicians in selecting treatments, and improving outcomes. In addition, mechanisms and processes that influence outcome will be studied, which will have the potential to lead to new treatment approaches and further improved outcomes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
3R01MH060998-09S1
Application #
8038657
Study Section
Special Emphasis Panel (ZRG1-BBBP-D (86))
Program Officer
Pearson, Jane L
Project Start
1999-12-01
Project End
2012-03-31
Budget Start
2010-09-27
Budget End
2012-03-31
Support Year
9
Fiscal Year
2010
Total Cost
$150,840
Indirect Cost
Name
University of Pennsylvania
Department
Psychology
Type
Schools of Arts and Sciences
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Furukawa, Toshi A; Weitz, Erica S; Tanaka, Shiro et al. (2017) Initial severity of depression and efficacy of cognitive-behavioural therapy: individual-participant data meta-analysis of pill-placebo-controlled trials. Br J Psychiatry 210:190-196
Cooper, Andrew A; Strunk, Daniel R; Ryan, Elizabeth T et al. (2016) The therapeutic alliance and therapist adherence as predictors of dropout from cognitive therapy for depression when combined with antidepressant medication. J Behav Ther Exp Psychiatry 50:113-9
Vittengl, Jeffrey R; Jarrett, Robin B; Weitz, Erica et al. (2016) Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression. Am J Psychiatry 173:481-90
Lorenzo-Luaces, Lorenzo; German, Ramaris E; DeRubeis, Robert J (2015) It's complicated: The relation between cognitive change procedures, cognitive change, and symptom change in cognitive therapy for depression. Clin Psychol Rev 41:3-15
Hollon, Steven D; DeRubeis, Robert J; Fawcett, Jan et al. (2014) Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry 71:1157-64
Derubeis, Robert J; Gelfand, Lois A; German, Ramaris E et al. (2014) Understanding processes of change: how some patients reveal more than others-and some groups of therapists less-about what matters in psychotherapy. Psychother Res 24:419-28
DeRubeis, Robert J; Cohen, Zachary D; Forand, Nicholas R et al. (2014) The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations. A demonstration. PLoS One 9:e83875
Cuijpers, Pim; Weitz, Erica; Twisk, Jos et al. (2014) Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an ""individual patient data"" meta-analysis. Depress Anxiety 31:941-51
Lorenzo-Luaces, Lorenzo; DeRubeis, Robert J; Webb, Christian A (2014) Client characteristics as moderators of the relation between the therapeutic alliance and outcome in cognitive therapy for depression. J Consult Clin Psychol 82:368-73
Amsterdam, Jay D; Luo, Lola; Shults, Justine (2013) Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder. Br J Psychiatry 202:301-6

Showing the most recent 10 out of 22 publications